References
Hazlewood GS, Rezaie A, Borman M, Panaccione R, Ghosh S, Seow CH, Kuenzig E, Tomlinson G, Siegel CA, Melmed GY, Kaplan GG (2015) Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn’s disease: a network meta-analysis. Gastroenterology 148:344–354. doi:10.1053/j.gastro.2014.10.011
Chebli JM, Gaburri PD, Chebli LA, da Rocha Ribeiro TC, Pinto AL, Ambrogini Júnior O, Damião AO (2014) A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy. Med Sci Monit 20:487–498. doi:10.12659/MSM.890331
Tsinganou E, Gebbers JO (2010) Human intestinal spirochetosis—a review. Ger Med Sci 8:1–7. doi:10.3205/000090
Körner M, Gebbers JO (2003) Clinical significance of human intestinal Spirochetosis—a morphologic approach. Infection 31:341–349
Carr NJ, Mahajan H, Tan KL, Sharma R (2010) The histological features of intestinal spirochetosis in a series of 113 patients. Int J Surg Pathol 18:144–148. doi:10.1177/1066896908330203
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
This report followed the ethical principles of the Declaration of Helsinki and was approved by the Federal University of Juiz de Fora Research Ethics Committee. The patient signed an informed consent form.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chebli, J.M.F., de Abreu, N.C., Chebli, L.A. et al. Intestinal spirochetosis: an unusual cause of IBD flare-up during anti-TNF therapy. Int J Colorectal Dis 31, 745–746 (2016). https://doi.org/10.1007/s00384-015-2240-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-015-2240-8